Page 5 - Cian Crosbie News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cian crosbie. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cian Crosbie Today - Breaking & Trending Today

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis

Sequana Medical submits Premarket Approval application to US FDA for alfapump® in recurrent or refractory ascites due to liver cirrhosis
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Timur Resch , Cian Crosbie , Health Solutions , Drug Administration , Company Or Sequanamedical , Sequana Medical , Euronext Brussels , Premarket Approval , Global Vice President , Chief Executive Officer , North American , Pivotal Cohort , Major Adverse Events , North American Consortium , End Stage Liver , North America , Glomerular Filtration Rate , End Stage Liver Disease ,

Sequana Medical N : announces additional alfapump data supporting strong and durable clinical profile; PMA on track for year-end submission -October 19, 2023 at 01:53 am EDT

REGULATED INFORMATION - INSIDE INFORMATION

19 October 2023, 07:00 am CEST

One-year alfapump data from POSEIDON shows safety and. ....

United States , Cian Crosbie , Gijs Klarenbeek , Health Solutions , Company Or Sequanamedical , American Consortium For The Study Of End , Sequana Medical , Euronext Brussels , Senior Medical Advisor , Chief Executive Officer , Major Adverse Events , Patient Preference , Pivotal Cohort , North American Consortium , End Stage Liver Disease , North America , Conference Call , North American , Pre Market Approval , Glomerular Filtration Rate , Institutional Review ,

Sequana Medical N : announces H1 2023 results and provides business update -September 14, 2023 at 04:37 am EDT

PRESS RELEASE

REGULATED INFORMATION - INSIDE INFORMATION

14 September 2023, 07:00 CEST

alfapump® - strong pivotal POSEIDON data. ....

United States , Cian Crosbie , Ken Macleod , Kenneth Macleod , Company Or Sequanamedical , Liver International , Good Laboratory Practice , Medicaid Services , Belgian Research Development , Pre Market Approval , Euronext Brussels , Chief Executive Officer , Sequana Medical , North American , Principal Investigator , Safety Monitoring Board , Rosetta Capital , Thousand Euros , Not Meaningful , Belgian Research , Bootstrap Warrants , Kreos Subscription Rights , Investor Warrants , Consolidated Statement , Condensed Consolidated Financial , Condensed Consolidated Financial Statements ,

Sequana Medical NV: Sequana Medical announces H1 2023 results and provides business update

Sequana Medical NV: Sequana Medical announces H1 2023 results and provides business update
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Kenneth Macleod , Cian Crosbie , Ken Macleod , Belgian Research Development , Liver International , Medicaid Services , Company Or Sequanamedical , Good Laboratory Practice , Pre Market Approval , Euronext Brussels , Chief Executive Officer , Sequana Medical , North American , Principal Investigator , Safety Monitoring Board , Rosetta Capital , Not Meaningful , Belgian Research , Bootstrap Warrants , Kreos Subscription Rights , Investor Warrants , Consolidated Statement , Condensed Consolidated Financial , Condensed Consolidated Financial Statements , Thousand Euros ,